TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Study TMC114-C214 is a randomized, controlled, open-label trial to compare the efficacy,
safety and tolerability of TMC114 boosted with low dose ritonavir (RTV) versus Kaletra
(LPV)/RTV in lopinavir-naïve treatment-experienced HIV-1 infected patients.